Biodesix Inc.

Last updated September 27, 2026

Organization details

Legal name
Biodesix Inc.
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
8071 — Services-Medical Laboratories
Jurisdiction of incorporation
Delaware
Headquarters city
Louisville
Headquarters state / province
Colorado
Headquarters country
United States
Fiscal year end
December
Ticker symbol
BDSX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001439725
EIN
20-3986492

Board of directors

Chief executives

Scott Hutton · President & CEO
Dates unknown

Director election results

Annual meeting of May 19, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

2 of this board's directors also sit on 2 other boards. 2 are in the same sector.

Network of Biodesix Inc.'s board connections Inhibrx Biosciences Inc. Inhibrx Biosciences In... QuidelOrtho Corporation QuidelOrtho Corporatio... Jon Faiz Kayyem Jon Faiz Kayyem Matthew Strobeck Matthew Strobeck Biodesix Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$3,117,678
6 purchases by 1 insider
Sold, last 12 months
$116,095
15 sales by 5 insiders
Date Insider Transaction Shares Price Value
Sep 30, 2026 John Patience Director, Chairman Option exercise +1,360 — —
Aug 12, 2026 Jack W. Schuler 10% owner, Emeritus Director Open-market purchase +15,000 $24.47 $367,050
Aug 11, 2026 Jack W. Schuler 10% owner, Emeritus Director Open-market purchase +13,700 $24.01 $328,937
Aug 10, 2026 Jack W. Schuler 10% owner, Emeritus Director Open-market purchase +13,900 $24.25 $337,075
Jun 30, 2026 John Patience Director, Chairman Option exercise +1,361 — —
Mar 31, 2026 John Patience Director, Chairman Option exercise +1,361 — —
Feb 23, 2026 Vazquez Chris Officer (Chief Accounting Officer) Open-market sale −211 $12.78 $2,697
Feb 23, 2026 Scott Hutton Director, Officer (President & CEO) Open-market sale −1,490 $12.78 $19,042
Feb 23, 2026 Pestano Gary Anthony Officer (Chief Development Officer) Open-market sale −556 $12.78 $7,106
Feb 23, 2026 O'Kane Kieran Officer (Chief Commercial Officer) Open-market sale −535 $12.78 $6,837
Feb 23, 2026 Cowie Robin Harper Officer (CFO, Sec'y & Treasurer) Open-market sale −535 $12.78 $6,837
Feb 20, 2026 Vazquez Chris Officer (Chief Accounting Officer) Option exercise +563 — —
Feb 20, 2026 Scott Hutton Director, Officer (President & CEO) Option exercise +4,844 — —
Feb 20, 2026 Pestano Gary Anthony Officer (Chief Development Officer) Option exercise +1,528 — —
Feb 20, 2026 O'Kane Kieran Officer (Chief Commercial Officer) Option exercise +1,469 — —

Organizations in the same sector, closest in location and size first.

Questions about Biodesix Inc.

Who is the CEO of Biodesix Inc.?

Scott Hutton is Biodesix Inc.'s President & CEO.

How many directors are on Biodesix Inc.'s board?

Biodesix Inc.'s board has 9 directors: Charles M. Watts, Hany Massarany, Jack W. Schuler, Jean M. Franchi, John Patience, Jon Faiz Kayyem, Lawrence T. Kennedy Jr., Matthew Strobeck and Scott Hutton.

Are Biodesix Inc. insiders buying or selling shares?

Over the last 12 months, Biodesix Inc. insiders bought $3.1 million of shares in 6 purchases and sold $116,095 of shares in 15 sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="biodesix-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.